CN111436429A - Pharmaceutical composition for environmental disinfection and preparation method thereof - Google Patents
Pharmaceutical composition for environmental disinfection and preparation method thereof Download PDFInfo
- Publication number
- CN111436429A CN111436429A CN202010198458.8A CN202010198458A CN111436429A CN 111436429 A CN111436429 A CN 111436429A CN 202010198458 A CN202010198458 A CN 202010198458A CN 111436429 A CN111436429 A CN 111436429A
- Authority
- CN
- China
- Prior art keywords
- composition
- ammonium chloride
- chloride
- dimethyl
- dodecyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004659 sterilization and disinfection Methods 0.000 title claims abstract description 73
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 40
- 230000007613 environmental effect Effects 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title abstract description 23
- 239000000203 mixture Substances 0.000 claims abstract description 56
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims abstract description 46
- 239000003381 stabilizer Substances 0.000 claims abstract description 34
- 239000008213 purified water Substances 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims description 42
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims description 23
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 23
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 20
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 20
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 15
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 15
- RUPBZQFQVRMKDG-UHFFFAOYSA-M Didecyldimethylammonium chloride Chemical group [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC RUPBZQFQVRMKDG-UHFFFAOYSA-M 0.000 claims description 10
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 claims description 6
- 229960001950 benzethonium chloride Drugs 0.000 claims description 6
- KHSLHYAUZSPBIU-UHFFFAOYSA-M benzododecinium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 KHSLHYAUZSPBIU-UHFFFAOYSA-M 0.000 claims description 6
- UMGXUWVIJIQANV-UHFFFAOYSA-M didecyl(dimethyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC UMGXUWVIJIQANV-UHFFFAOYSA-M 0.000 claims description 6
- JMHWNJGXUIJPKG-UHFFFAOYSA-N CC(=O)O[SiH](CC=C)OC(C)=O Chemical compound CC(=O)O[SiH](CC=C)OC(C)=O JMHWNJGXUIJPKG-UHFFFAOYSA-N 0.000 claims description 4
- JBIROUFYLSSYDX-UHFFFAOYSA-M benzododecinium chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 JBIROUFYLSSYDX-UHFFFAOYSA-M 0.000 claims description 4
- -1 miropyram Chemical compound 0.000 claims description 4
- CBFCDTFDPHXCNY-UHFFFAOYSA-N octyldodecane Natural products CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 claims description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims description 2
- 229920000388 Polyphosphate Polymers 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 2
- SXPWTBGAZSPLHA-UHFFFAOYSA-M cetalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SXPWTBGAZSPLHA-UHFFFAOYSA-M 0.000 claims description 2
- 229960000228 cetalkonium chloride Drugs 0.000 claims description 2
- SCXCDVTWABNWLW-UHFFFAOYSA-M decyl-dimethyl-octylazanium;chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCC SCXCDVTWABNWLW-UHFFFAOYSA-M 0.000 claims description 2
- VUFOSBDICLTFMS-UHFFFAOYSA-M ethyl-hexadecyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)CC VUFOSBDICLTFMS-UHFFFAOYSA-M 0.000 claims description 2
- 229920000768 polyamine Polymers 0.000 claims description 2
- 239000001205 polyphosphate Substances 0.000 claims description 2
- 235000011176 polyphosphates Nutrition 0.000 claims description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims 5
- BDOYKFSQFYNPKF-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;sodium Chemical compound [Na].[Na].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O BDOYKFSQFYNPKF-UHFFFAOYSA-N 0.000 claims 1
- DUSGZPHDYXXYGD-UHFFFAOYSA-L [Cl-].Cl[Po+] Chemical compound [Cl-].Cl[Po+] DUSGZPHDYXXYGD-UHFFFAOYSA-L 0.000 claims 1
- OCBHHZMJRVXXQK-UHFFFAOYSA-M benzyl-dimethyl-tetradecylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 OCBHHZMJRVXXQK-UHFFFAOYSA-M 0.000 claims 1
- 229960004670 didecyldimethylammonium chloride Drugs 0.000 claims 1
- 239000000645 desinfectant Substances 0.000 abstract description 34
- 229940079593 drug Drugs 0.000 abstract description 22
- 239000003814 drug Substances 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 18
- 230000000295 complement effect Effects 0.000 abstract 1
- 241000588724 Escherichia coli Species 0.000 description 35
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical group OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 32
- 241000191967 Staphylococcus aureus Species 0.000 description 32
- 230000003385 bacteriostatic effect Effects 0.000 description 30
- 230000000844 anti-bacterial effect Effects 0.000 description 29
- 238000012360 testing method Methods 0.000 description 28
- 239000000243 solution Substances 0.000 description 21
- 241000222122 Candida albicans Species 0.000 description 20
- 229960000686 benzalkonium chloride Drugs 0.000 description 20
- 229940095731 candida albicans Drugs 0.000 description 20
- 230000002147 killing effect Effects 0.000 description 18
- 238000012216 screening Methods 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 9
- 230000009969 flowable effect Effects 0.000 description 9
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- 238000010790 dilution Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 8
- 230000001954 sterilising effect Effects 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 241000700605 Viruses Species 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 230000002195 synergetic effect Effects 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 6
- 229960001716 benzalkonium Drugs 0.000 description 6
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 6
- IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 6
- 208000035473 Communicable disease Diseases 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 229960002233 benzalkonium bromide Drugs 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 244000144972 livestock Species 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 244000144977 poultry Species 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- KMVDECFGXJKYHV-UHFFFAOYSA-L trimethyl-[10-(trimethylazaniumyl)decyl]azanium;dichloride Chemical compound [Cl-].[Cl-].C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C KMVDECFGXJKYHV-UHFFFAOYSA-L 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 208000031295 Animal disease Diseases 0.000 description 2
- FARBQUXLIQOIDY-UHFFFAOYSA-M Dioctyldimethylammonium chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(C)CCCCCCCC FARBQUXLIQOIDY-UHFFFAOYSA-M 0.000 description 2
- 241000991587 Enterovirus C Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000010359 Newcastle Disease Diseases 0.000 description 2
- 241000125945 Protoparvovirus Species 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003042 antagnostic effect Effects 0.000 description 2
- 206010064097 avian influenza Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- TXOJCSIIFFMREV-UHFFFAOYSA-L didecyl(dimethyl)azanium;carbonate Chemical compound [O-]C([O-])=O.CCCCCCCCCC[N+](C)(C)CCCCCCCCCC.CCCCCCCCCC[N+](C)(C)CCCCCCCCCC TXOJCSIIFFMREV-UHFFFAOYSA-L 0.000 description 2
- 241001493065 dsRNA viruses Species 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- KPJKMUJJFXZGAX-UHFFFAOYSA-N 2-chloropropan-2-ylbenzene Chemical compound CC(C)(Cl)C1=CC=CC=C1 KPJKMUJJFXZGAX-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241001260012 Bursa Species 0.000 description 1
- 208000027312 Bursal disease Diseases 0.000 description 1
- SBRHIQVQSGMQGZ-UHFFFAOYSA-N CCCCCCCCCCCCCCC1=C(C(C)(C)Cl)C=CC=C1.N Chemical compound CCCCCCCCCCCCCCC1=C(C(C)(C)Cl)C=CC=C1.N SBRHIQVQSGMQGZ-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 1
- 241001533384 Circovirus Species 0.000 description 1
- 101000868789 Drosophila melanogaster Carboxypeptidase D Proteins 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 101001013832 Homo sapiens Mitochondrial peptide methionine sulfoxide reductase Proteins 0.000 description 1
- 208000002979 Influenza in Birds Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 102100031767 Mitochondrial peptide methionine sulfoxide reductase Human genes 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 description 1
- 241001103617 Pseudomonas aeruginosa ATCC 15442 Species 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 208000035472 Zoonoses Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- DLNWMWYCSOQYSQ-UHFFFAOYSA-M benzyl-hexadecyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 DLNWMWYCSOQYSQ-UHFFFAOYSA-M 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940115457 cetyldimethylethylammonium bromide Drugs 0.000 description 1
- RLGQACBPNDBWTB-UHFFFAOYSA-N cetyltrimethylammonium ion Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)C RLGQACBPNDBWTB-UHFFFAOYSA-N 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- RMKNCYHVESPYFD-UHFFFAOYSA-N decan-1-amine;hydrochloride Chemical compound [Cl-].CCCCCCCCCC[NH3+] RMKNCYHVESPYFD-UHFFFAOYSA-N 0.000 description 1
- ICKLSPKTPKWFAP-UHFFFAOYSA-N diazanium;bromide;chloride Chemical compound [NH4+].[NH4+].[Cl-].[Br-] ICKLSPKTPKWFAP-UHFFFAOYSA-N 0.000 description 1
- JQRYDCPSJSWQGZ-UHFFFAOYSA-N didecylazanium;chloride Chemical group Cl.CCCCCCCCCCNCCCCCCCCCC JQRYDCPSJSWQGZ-UHFFFAOYSA-N 0.000 description 1
- WLCFKPHMRNPAFZ-UHFFFAOYSA-M didodecyl(dimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCC WLCFKPHMRNPAFZ-UHFFFAOYSA-M 0.000 description 1
- ZCPCLAPUXMZUCD-UHFFFAOYSA-M dihexadecyl(dimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCC ZCPCLAPUXMZUCD-UHFFFAOYSA-M 0.000 description 1
- RSHHCURRBLAGFA-UHFFFAOYSA-M dimethyl-di(tetradecyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCC RSHHCURRBLAGFA-UHFFFAOYSA-M 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- URXQDXAVUYKSCK-UHFFFAOYSA-N hexadecyl(dimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[NH+](C)C URXQDXAVUYKSCK-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229960002523 mercuric chloride Drugs 0.000 description 1
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- NQMRYBIKMRVZLB-UHFFFAOYSA-N methylamine hydrochloride Chemical compound [Cl-].[NH3+]C NQMRYBIKMRVZLB-UHFFFAOYSA-N 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- AFQGAXFMOMNYDL-UHFFFAOYSA-N n-octyloctan-1-amine;hydrochloride Chemical compound Cl.CCCCCCCCNCCCCCCCC AFQGAXFMOMNYDL-UHFFFAOYSA-N 0.000 description 1
- GMMYSKGRQQKXIU-UHFFFAOYSA-N n-tetradecyltetradecan-1-amine;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCNCCCCCCCCCCCCCC GMMYSKGRQQKXIU-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920000371 poly(diallyldimethylammonium chloride) polymer Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 206010048282 zoonosis Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
- A01N33/02—Amines; Quaternary ammonium compounds
- A01N33/12—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/22—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing ingredients stabilising the active ingredients
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
- A01N35/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals
Landscapes
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Toxicology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
本发明提供了一种环境消毒用药物组合物及其制备方法,涉及兽用消毒剂领域,所述组合物,每1L中包括单链季铵盐30~200g,双链季铵盐50~300g,溶液稳定剂0.005~0.5g,酸碱调节剂0.5~3g,其余为纯化水。本发明的组合物制备工艺简单,用药成本低,稳定性好,消毒效果好,本发明的组合物,其中稳定剂选用市场上新颖的、安全的稳定剂,以及适宜的酸碱度范围,本组合物的酸碱度与溶液稳定剂相互作用,相辅相成,共同组成了本发明组合物的稳定体系,使消毒效果更持久。The invention provides a pharmaceutical composition for environmental disinfection and a preparation method thereof, and relates to the field of veterinary disinfectants. The composition comprises 30-200 g of single-chain quaternary ammonium salt and 50-300 g of double-chain quaternary ammonium salt per 1 L , solution stabilizer 0.005 ~ 0.5g, acid-base regulator 0.5 ~ 3g, and the rest are purified water. The composition of the present invention has simple preparation process, low drug cost, good stability and good disinfection effect. The composition of the present invention, wherein the stabilizer is selected from novel and safe stabilizers on the market, and a suitable pH range, the composition of the present invention The pH and the solution stabilizer interact and complement each other to form the stable system of the composition of the present invention, so that the disinfection effect is more durable.
Description
技术领域technical field
本发明涉及兽用消毒剂领域,特别涉及一种用于环境消毒的含有单链季铵盐和双链季铵盐的药物组合物及其制备方法。The invention relates to the field of veterinary disinfectants, in particular to a pharmaceutical composition containing single-chain quaternary ammonium salt and double-chain quaternary ammonium salt for environmental disinfection and a preparation method thereof.
背景技术Background technique
近年来接连发生的重大动物疫病不仅使我国畜牧业遭受巨大经济损失,甚至直接威 胁到人的健康。并且目前动物疫病的发生大有愈演愈烈之势。In recent years, the successive major animal diseases have not only caused huge economic losses to my country's animal husbandry, but also directly threatened human health. And at present, the occurrence of animal diseases is on the rise.
动物传染病的流行必须具备3个最基本的条件,即传染源、传播途径和易感动物,而且只有当这3个条件同时存在并相互联系才能使传染病在动物群体中流行。目前我国对于 动物传染病的控制主要有疫苗免疫、药物防治、环境消毒三种方式。但是由于“重养轻防, 轻防重治”思想的普遍存在对于动物传染病的控制主要依赖疫苗免疫和药物防治。The prevalence of zoonotic diseases must meet three basic conditions, namely the source of infection, the route of transmission and the susceptible animals, and only when these three conditions exist at the same time and are connected with each other can infectious diseases become popular in animal groups. At present, the control of animal infectious diseases in my country mainly includes three methods: vaccine immunization, drug prevention and control, and environmental disinfection. However, due to the widespread existence of the idea of "emphasizing maintenance and neglecting prevention, and focusing on prevention and treatment", the control of animal infectious diseases mainly relies on vaccine immunization and drug prevention and treatment.
消毒是贯彻预防为主方针的首要的措施。通常利用消毒剂对畜禽(包括动物体表皮肤粘膜和体表浅体腔)及其周围环境进行消毒以杀灭病原体减少病原体对饲养环境的污染,切断疾病的传播途径,达到防止疾病发生、蔓延,进而控制和消灭传染病的目的。所以彻底、规范的消毒是一种最有效、最方便的预防及控制疾病的方法手段。利用消毒剂对畜禽及其周围环境进行消毒以杀灭病原体已成为预防和控制畜禽传染病流行的重要措施。Disinfection is the primary measure to implement the prevention-oriented policy. Disinfectants are usually used to disinfect livestock and poultry (including animal skin and mucous membranes and superficial body cavities) and their surrounding environment to kill pathogens, reduce the pollution of pathogens to the breeding environment, cut off the transmission route of diseases, and prevent the occurrence and spread of diseases. , and then control and eliminate the purpose of infectious diseases. Therefore, thorough and standardized disinfection is the most effective and convenient method to prevent and control diseases. The use of disinfectants to disinfect livestock and poultry and their surrounding environment to kill pathogens has become an important measure to prevent and control the epidemic of livestock and poultry infectious diseases.
目前使用的化学消毒剂多以单方消毒剂为主,如苯酚、甲醛、乙醇、漂白粉等。 但由于单方兽用消毒剂往往存在消毒谱和使用范围较窄,稳定性差,腐蚀性、刺激性、毒性 较强,消毒性能易受其他物质影响,价格昂贵等不足,消毒效果不够理想,使用受到一定的 限制。因此,开发兽用复方消毒剂以提高杀菌效果、克服单方兽用消毒剂存在的缺点尤为必要。因此,针对当前我国畜禽养殖业因养殖环境差引起得疫病频繁暴发以及兽用消毒剂生产 企业创新能力薄弱的现状,开展对禽流感病毒、圆环病毒、蓝耳病病毒、口蹄疫病毒、链球 菌等多种致病微生物具有杀灭作用的高效安全广谱复方消毒剂的研究,是保障我国畜牧业健 康发展、提高人民生活水平的迫切需求。因此开发一种消毒效果好、稳定性高、杀菌消毒作 用时间长的环境消毒用药物组合物意义重大。The chemical disinfectants currently used are mostly unilateral disinfectants, such as phenol, formaldehyde, ethanol, bleaching powder, etc. However, due to the fact that unilateral veterinary disinfectants often have a narrow disinfection spectrum and a narrow range of use, poor stability, strong corrosiveness, irritation, and toxicity, the disinfection performance is easily affected by other substances, and the price is expensive. certain restrictions. Therefore, it is particularly necessary to develop compound veterinary disinfectants to improve the bactericidal effect and overcome the shortcomings of unilateral veterinary disinfectants. Therefore, in view of the current situation of frequent outbreaks of epidemic diseases in my country's livestock and poultry breeding industry due to poor breeding environment and the weak innovation ability of veterinary disinfectant manufacturers, carry out investigations on avian influenza virus, circovirus, PRRS virus, foot-and-mouth disease virus, chain The research on efficient and safe broad-spectrum compound disinfectant with killing effect on various pathogenic microorganisms such as cocci is an urgent need to ensure the healthy development of animal husbandry in my country and improve people's living standards. Therefore, it is of great significance to develop a pharmaceutical composition for environmental disinfection with good disinfection effect, high stability and long sterilization and disinfection time.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于提供一种工艺简单,消毒效果好,稳定性高,杀菌消毒作用时间长,成本低的环境消毒用药物组合物。本发明的药物组合物由单链季铵盐、双链季铵盐、溶液稳定剂、酸碱调节剂等成分组成,本发明还提供了一种环境消毒用药物组合物的制备方 法。本发明的组合物对RNA病毒、细小病毒、腺病毒、脊髓灰质炎病毒、禽流感、新城疫、传染性法氏囊等细菌病毒效果明显。The object of the present invention is to provide a pharmaceutical composition for environmental disinfection with simple process, good disinfection effect, high stability, long sterilization and disinfection time and low cost. The pharmaceutical composition of the present invention is composed of components such as single-chain quaternary ammonium salt, double-chain quaternary ammonium salt, solution stabilizer, acid-base regulator, etc. The present invention also provides a preparation method of a pharmaceutical composition for environmental disinfection. The composition of the present invention has obvious effect on bacterial viruses such as RNA virus, parvovirus, adenovirus, poliovirus, avian influenza, Newcastle disease, infectious bursa.
本发明的另一目的在于提供一种与常规环境消毒用药物组合物相比更优的环境消毒用药物组合物。该组合物用乙二胺四乙酸二钠与Provichem 2203的组合物作为溶液稳定剂得到的一种环境消毒用药物组合物,与其他一些发明得到的一种环境消毒用药物组合物 相比,该组合物稳定性更高,杀菌消毒效果更好。并且选用乙二胺四乙酸二钠与Provichem 2203的组合物作为溶液稳定剂得到的一种环境消毒用药物组合物,当组合物体系pH值为 8~10时,与体系pH值不在8~10范围内的组合物相比,该组合物杀菌消毒作用时间更长。Another object of the present invention is to provide a pharmaceutical composition for environmental disinfection that is superior to conventional pharmaceutical compositions for environmental disinfection. The composition uses the composition of disodium EDTA and Provichem 2203 as a solution stabilizer to obtain a pharmaceutical composition for environmental disinfection, compared with a pharmaceutical composition for environmental disinfection obtained by other inventions, the The composition has higher stability and better sterilization and disinfection effect. And select the composition of disodium EDTA and Provichem 2203 as a solution stabilizer to obtain a pharmaceutical composition for environmental disinfection, when the pH value of the composition system is 8 to 10, the pH value of the system is not in the range of 8 to 10. The composition has a longer sterilization and disinfection time than the composition within the range.
本发明的另一目的在于提供一种环境消毒用药物组合物。Another object of the present invention is to provide a pharmaceutical composition for environmental disinfection.
为实现上述发明目的,本发明所采用的技术方案是:For realizing the above-mentioned purpose of the invention, the technical scheme adopted in the present invention is:
一种环境消毒用药物组合物,其特征在于,所述组合物,每1L中包括单链季铵盐30~200g, 双链季铵盐50~300g,溶液稳定剂0.005~0.5g,酸碱调节剂0.5~3g,其余为纯化水。A pharmaceutical composition for environmental disinfection, characterized in that each 1L of the composition includes 30-200 g of single-chain quaternary ammonium salt, 50-300 g of double-chain quaternary ammonium salt, 0.005-0.5 g of solution stabilizer, acid-base Conditioner 0.5~3g, the rest is purified water.
其中,所述的单链季铵盐选自:十二烷基二甲基苄基溴化铵、十二烷基二甲基苄基氯化铵、 十四烷基二甲基苄基氯化铵、十六烷基二甲基乙基溴化铵、十六烷基二甲基苄基溴化铵、十 六烷基二甲基苄基氯化铵、米吡氯铵、泊利氯铵、苄索氯铵中的一种或两种以上的组合物; 其中,所述的十二烷基二甲基苄基氯化铵选自:十二烷基(60%C14,30%C16,5%C18,5%C12) 二甲基苄基氯化铵、十二烷基(50%C12,30%C14,17%C17,3%C18)二甲基苄基氯化铵、 十二烷基(100%C14)二甲基苄基氯化铵、十二烷基(50%C14,40%C12,10%C16)二甲基苄基氯化铵、十二烷基(58%C14,28%C16,14%C12)二甲基苄基氯化铵中的一种。Wherein, the single-chain quaternary ammonium salt is selected from: dodecyldimethylbenzyl ammonium bromide, dodecyldimethylbenzyl ammonium chloride, tetradecyldimethylbenzyl chloride Ammonium, Cetyl Dimethyl Ethyl Ammonium Bromide, Cetyl Dimethyl Benzyl Ammonium Bromide, Cetyl Dimethyl Benzyl Ammonium Chloride, Cetyl Dimethyl Ammonium Chloride, Poridium Chloride , one or more compositions of benzethonium chloride; wherein, the dodecyl dimethyl benzyl ammonium chloride is selected from: dodecyl (60% C 14 , 30% C 16 , 5% C 18 , 5% C 12 ) dimethylbenzyl ammonium chloride, dodecyl (50% C 12 , 30% C 14 , 17% C 17 , 3% C 18 ) dimethyl benzyl ammonium chloride, dodecyl (100% C 14 ) dimethylbenzyl ammonium chloride, dodecyl (50% C 14 , 40% C 12 , 10% C 16 ) dimethylbenzyl chloride One of ammonium chloride and dodecyl (58% C 14 , 28% C 16 , 14% C 12 ) dimethylbenzyl ammonium chloride.
其中,所述的双链季铵盐选自:二辛基二甲基氯化铵、辛基癸基二甲基氯化铵、双癸基二甲 基氯化铵、二癸基/二辛基二甲基氯化铵、双辛烷基二甲基氯化铵、双十烷基二甲基溴化铵 中的一种或两种以上的组合物。Wherein, the described double-chain quaternary ammonium salt is selected from: dioctyl dimethyl ammonium chloride, octyl decyl dimethyl ammonium chloride, bis-decyl dimethyl ammonium chloride, didecyl/dioctyl ammonium chloride A combination of one or more of the group consisting of bis-octyl dimethyl ammonium chloride, bis-octyl dimethyl ammonium chloride and bis-decyl dimethyl ammonium bromide.
其中,所述的溶液稳定剂选自:多磷酸盐、1,3-二酮、羟基羧酸、乙二胺四乙酸二钠、多胺、 氨基羧酸、Provichem 2202、Provichem 2203、HT-944、聚乙烯醇中的一种或两种以上的组 合物。优选的所述的溶液稳定剂选自:乙二胺四乙酸二钠与Provichem 2203的组合物;所述 的乙二胺四乙酸二钠与Provichem 2203两者重量比例为1:1~10:1,最优选的所述的溶液稳 定剂选自:乙二胺四乙酸二钠与Provichem 2203的组合物;乙二胺四乙酸二钠与Provichem 2203组合物的重量比例为3:1。Wherein, the solution stabilizer is selected from: polyphosphate, 1,3-diketone, hydroxycarboxylic acid, disodium EDTA, polyamine, aminocarboxylic acid, Provichem 2202, Provichem 2203, HT-944 , polyvinyl alcohol in one or two or more compositions. Preferably, the solution stabilizer is selected from: the composition of disodium EDTA and Provichem 2203; the weight ratio between the disodium EDTA and Provichem 2203 is 1:1 to 10:1 , the most preferred solution stabilizer is selected from: the composition of disodium EDTA and Provichem 2203; the weight ratio of disodium EDTA and the composition of Provichem 2203 is 3:1.
其中,所述组合物pH值为8~10。Wherein, the pH value of the composition is 8-10.
最优选的,本发明所述组合物,每1L中包括100g十二烷基(50%C14,40%C12,10%C16)二甲基苄基氯化铵,150g双癸基二甲基氯化铵,0.06g乙二胺四乙酸二钠,0.02g Provichem2203,酸碱调节剂适量至pH为8~10,其余为纯化水。Most preferably, the composition of the present invention includes 100 g dodecyl (50% C 14 , 40% C 12 , 10% C 16 ) dimethylbenzyl ammonium chloride, 150 g bisdecyl dichloride per 1 L Methyl ammonium chloride, 0.06g disodium EDTA, 0.02g Provichem2203, appropriate amount of acid-base regulator to pH 8-10, and the rest are purified water.
本发明的组合物的制备方法包括如下步骤:The preparation method of the composition of the present invention comprises the following steps:
1)将单链季铵盐原料药与适量纯化水混合,于70℃加热使其完全熔融成可流动状态;1) Mix the single-chain quaternary ammonium salt bulk drug with an appropriate amount of purified water, and heat it at 70°C to completely melt it into a flowable state;
2)依次加入双链季铵盐、溶液稳定剂于搅拌器上搅拌均匀;2) Add the double-chain quaternary ammonium salt and the solution stabilizer successively and stir evenly on the stirrer;
3)用酸碱调节剂调节本环境消毒用药物组合物的pH值为8~10,定容即得。3) The pH value of the pharmaceutical composition for environmental disinfection is adjusted to 8-10 with an acid-base regulator, and the volume is constant.
优选的,本发明的组合物的制备方法包括如下步骤:将单链季铵盐原料药与适量纯化水混合,于70℃加热使其完全熔融成可流动状态;依次加入双链季铵盐、溶液稳定剂于搅拌器上搅拌均匀;用酸碱调节剂调节本环境消毒用药物组合物的pH值为8~10,定容即得。Preferably, the preparation method of the composition of the present invention includes the following steps: mixing the single-chain quaternary ammonium salt bulk drug with an appropriate amount of purified water, heating at 70° C. to make it completely melted into a flowable state; sequentially adding the double-chain quaternary ammonium salt, The solution stabilizer is stirred evenly on the stirrer; the pH value of the pharmaceutical composition for environmental disinfection is adjusted to 8-10 with an acid-base regulator, and the volume is determined.
本发明制得的一种环境消毒用药物组合物主要成分为十二烷基(50%C14,40%C12, 10%C16)二甲基苄基氯化铵及双癸基二甲基氯化铵。十二烷基(50%C14,40%C12,10%C16) 二甲基苄基氯化铵为单链季铵盐,双癸基二甲基氯化铵为双链季铵盐。季铵盐的杀灭微生物 作用源自于其分子中季铵氮的阳离子头基与细胞膜中的酸性磷脂的带负电头基之间的相互 作用,一旦二者结合,季铵盐的疏水尾基就会嵌入到微生物疏水膜的内部,在较高的季铵盐 浓度下,细胞膜就会与季铵盐形成混合胶束聚集体从而被瓦解。季铵盐类消毒剂在低浓度下 有抑菌作用,较高浓度时可杀灭大多数种类的细菌繁殖体与部分病毒。The main components of the pharmaceutical composition for environmental disinfection prepared by the invention are dodecyl (50% C 14 , 40% C 12 , 10% C 16 ) dimethylbenzyl ammonium chloride and bisdecyl dimethyl ammonium chloride. Dodecyl (50% C 14 , 40% C 12 , 10% C 16 ) dimethylbenzyl ammonium chloride is a single chain quaternary ammonium salt, and bisdecyl dimethyl ammonium chloride is a double chain quaternary ammonium salt . The microbial killing effect of quaternary ammonium salts originates from the interaction between the cationic head group of quaternary ammonium nitrogen in its molecule and the negatively charged head group of acidic phospholipids in the cell membrane. Once the two are combined, the hydrophobic tail group of quaternary ammonium salts At higher quaternary ammonium salt concentrations, the cell membrane will form mixed micellar aggregates with quaternary ammonium salts and be disintegrated. Quaternary ammonium salt disinfectants have bacteriostatic effect at low concentrations, and can kill most types of bacterial propagules and some viruses at higher concentrations.
本发明制得的一种环境消毒用药物组合物制备工艺简单,消毒效果好,稳定性高,杀菌消毒作用时间长,成本低,适合规模化工业生产,对畜牧业的可持续发展具有重大意义。The pharmaceutical composition for environmental disinfection prepared by the invention has simple preparation process, good disinfection effect, high stability, long sterilization and disinfection time, low cost, is suitable for large-scale industrial production, and has great significance for the sustainable development of animal husbandry. .
本发明制得的一种环境消毒用药物组合物为与常规环境消毒用药物组合物相比更优的环境消毒用药物组合物,该组合物用乙二胺四乙酸二钠与Provichem 2203的组合物作为溶液稳定剂得到的一种环境消毒用药物组合物,与其他一些发明得到的一种环境消毒用 药物组合物相比,该组合物稳定性更高,杀菌消毒效果更好。并且选用乙二胺四乙酸二钠与 Provichem 2203的组合物作为溶液稳定剂得到的一种环境消毒用药物组合物,当组合物体系 pH值为8~10时,与体系pH值不在8~10范围内的组合物相比,该组合物杀菌消毒作用 时间更长。The pharmaceutical composition for environmental disinfection prepared by the present invention is a better pharmaceutical composition for environmental disinfection than conventional pharmaceutical compositions for environmental disinfection. The composition uses a combination of disodium EDTA and Provichem 2203. Compared with a pharmaceutical composition for environmental disinfection obtained by other inventions, the composition has higher stability and better sterilization and disinfection effect. And select the composition of disodium EDTA and Provichem 2203 as a solution stabilizer to obtain a pharmaceutical composition for environmental disinfection, when the pH value of the composition system is 8 to 10, the pH value of the system is not in the range of 8 to 10. The composition has a longer sterilization and disinfection time than the composition within the range.
目前,市场上已有的季铵盐杀灭微生物药物有:苯扎溴铵溶液、苯扎氯铵溶液、 复方戊二醛溶液,其中各组成和本发明类型的为:苯扎氯铵溶液、复方戊二醛溶液。At present, the existing quaternary ammonium salts on the market kill microorganisms: benzalkonium bromide solution, benzalkonium chloride solution, compound glutaraldehyde solution, wherein each composition and the type of the present invention are: benzalkonium chloride solution, Compound glutaraldehyde solution.
其组分包括:苯扎氯铵溶液主要成分为苯扎氯铵,复方戊二醛溶液主要成分为戊二醛和苯扎氯铵。The components include: the main components of the benzalkonium chloride solution are benzalkonium chloride, and the main components of the compound glutaraldehyde solution are glutaraldehyde and benzalkonium chloride.
其缺点是:苯扎氯铵溶液为单链季铵盐单方制剂,其消毒范围窄,只针对特定的细菌;复方戊二醛溶液为戊二醛和单链季铵盐复配的制剂,其消毒范围没有单链季铵盐和双 链季铵盐复配广,制剂杀菌起效时间长,一般要达到10个小时以上,且戊二醛有一定毒性, 可引起支气管炎及肺水肿。The disadvantage is: the benzalkonium chloride solution is a single-chain quaternary ammonium salt single preparation, and its disinfection range is narrow, only for specific bacteria; the compound glutaraldehyde solution is a compound preparation of glutaraldehyde and single-chain quaternary ammonium salt, and its disinfection range is narrow. The scope of disinfection is not as wide as that of single-chain quaternary ammonium salts and double-chain quaternary ammonium salts, and the preparation takes a long time to sterilize, generally more than 10 hours, and glutaraldehyde has certain toxicity, which can cause bronchitis and pulmonary edema.
其和本发明的主要差异在于:已知的季铵盐的杀灭微生物药物对细菌、病毒的杀灭范围窄,而本发明的组合物对RNA病毒、细小病毒、腺病毒、脊髓灰质炎病毒、禽流感、 新城疫、传染性法氏囊等多种细菌病毒效果明显;已知的季铵盐的杀灭微生物药物消毒作用时间短,且杀菌起效时间长,而本发明的组合物消毒作用更持久,并且在2.5min左右时, 可对多种细菌病毒的杀灭率能达到99.9%以上。The main difference between it and the present invention is that the known quaternary ammonium salts have a narrow range of killing bacteria and viruses, while the composition of the present invention is effective against RNA viruses, parvoviruses, adenoviruses, and polioviruses. , bird flu, Newcastle disease, infectious bursal disease and other bacteria and viruses have obvious effects; the known quaternary ammonium salts have a short sterilization time for killing microorganisms, and a long sterilization onset time, and the composition of the present invention sterilizes The effect is more durable, and the killing rate of various bacteria and viruses can reach more than 99.9% in about 2.5 minutes.
目前报道的含有与本发明相同成分的产品有:兽用消毒剂及其制备方法(申请号:200910087914.5,与本发明类似的成分包括苯扎氯铵和二癸基二甲基溴化铵)、一种利用季铵盐与醇制备的新型消毒液(申请号:201410807324.6,与本发明类似的成分包括苯扎氯铵、 苯扎溴铵、十六烷基三甲基铵、双葵基二甲基铵、烷基三甲基碳酸铵中的至少一种)、季铵 盐聚合物和共聚物的消毒剂(申请号:200680039366.3,与本发明类似的成分包括苯扎氯铵、 苄索氯铵、二甲基二癸基氯化铵或它们的混合物)、可高倍数稀释使用的消毒剂、制备方法 和用途(申请号:201010216594.1,与本发明类似的成分包括二甲基双十二烷基氯化铵、苯 扎溴胺、苯扎氯铵、十二烷基二甲基乙苯氧乙基溴化铵、二甲基双葵基氯化铵、二甲基双葵 基溴化铵、二甲基双葵基碳酸铵、二甲基双十四烷基氯化铵、二甲基双十六烷基氯化铵、苯 索氯铵中的一种或两种以上的混合物)、食品领域消毒剂及制备方法(申请号:201010219496.3,与本发明类似的成分包括苯扎溴胺、苯扎氯铵、二甲基双十二烷基氯化铵、 二甲基双十六烷基氯化铵、十二烷基二甲基乙苯氧乙基溴化铵、二甲基双葵基氯化铵、二甲 基双葵基溴化铵、二甲基双葵基碳酸铵、二甲基双十四烷基氯化铵、苯索氯铵中的一种或两 种以上)及局部抗微生物组合物(申请号:201780025348.8,与本发明类似的成分包括二癸 基二甲基氯化铵、苄索氯铵、苯扎氯铵、聚二烯丙基二甲基氯化铵或其混合物)。The currently reported products containing the same components as the present invention include: veterinary disinfectant and preparation method thereof (application number: 200910087914.5, the components similar to the present invention include benzalkonium chloride and didecyldimethylammonium bromide), A novel disinfectant prepared by utilizing quaternary ammonium salt and alcohol (application number: 201410807324.6, and the components similar to the present invention include benzalkonium chloride, benzalkonium bromide, cetyltrimethylammonium, bisdecyldimethylammonium At least one of base ammonium, alkyl trimethyl ammonium carbonate), quaternary ammonium salt polymer and copolymer disinfectant (application number: 200680039366.3, similar components to the present invention include benzalkonium chloride, benzethonium chloride , dimethyl didecyl ammonium chloride or their mixture), disinfectant that can be used in high multiple dilution, preparation method and use (application number: 201010216594.1, similar components to the present invention include dimethyl didecyl Ammonium chloride, benzalkonium bromide, benzalkonium chloride, dodecyldimethylethoxyethylammonium bromide, dimethyl bisdecyl ammonium chloride, dimethyl bisdecyl ammonium bromide, One or more mixtures of dimethyl bisdecyl ammonium carbonate, dimethyl bistetradecyl ammonium chloride, dimethyl bishexadecyl ammonium chloride, benzethonium chloride), food Field disinfectant and preparation method (application number: 201010219496.3, the components similar to the present invention include benzalkonium bromide, benzalkonium chloride, dimethyldidodecylammonium chloride, dimethyldihexadecyl chloride Ammonium bromide, Dodecyldimethylethoxyethylammonium bromide, Dimethylbisdecylammonium chloride, Dimethylbisdecylammonium bromide, Dimethylbisdecylammonium carbonate, Dimethyl bisdecylammonium bromide One or more of ditetradecyl ammonium chloride and benzethonium chloride) and topical antimicrobial composition (application number: 201780025348.8, the components similar to the present invention include didecyl dimethyl chloride ammonium, benzethonium chloride, benzalkonium chloride, polydiallyldimethylammonium chloride or mixtures thereof).
兽用消毒剂及其制备方法(申请号:200910087914.5)仅公布了不同倍数稀释对大肠杆菌和金黄色葡萄球菌10min内的平均杀菌率;一种利用季铵盐与醇制备的新型消毒液(申请号:201410807324.6)仅公布了对大肠杆菌8099、金黄色葡萄球菌ATCC6538、白 色念珠菌ATCC10231、绿脓杆菌ATCC15442和黑曲霉菌5min内的平均杀菌率;季铵盐聚 合物和共聚物的消毒剂(申请号:200680039366.3)仅公布了对大肠杆菌、金黄色葡萄球菌、 MSRA、耐万古霉素粪肠球菌48h内的平均抑菌能力;可高倍数稀释使用的消毒剂、制备方 法和用途(申请号:201010216594.1)仅公布了不同倍数稀释对大肠杆菌、白色念珠菌和金 黄色葡萄球菌20min内的平均杀菌率;食品领域消毒剂及制备方法(申请号: 201010219496.3)仅公布了不同倍数稀释对大肠杆菌10min内的平均杀菌效果;局部抗微生 物组合物(申请号:201780025348.8)仅公布了不同倍数稀释对大肠杆菌3h内的平均杀菌 效果。以上报道的含有与本发明相同成分的产品均未体现其长期杀菌率效果。Veterinary disinfectant and its preparation method (application number: 200910087914.5) only announced the average bactericidal rate of Escherichia coli and Staphylococcus aureus within 10min of different multiple dilutions; a new type of disinfectant prepared by utilizing quaternary ammonium salt and alcohol (application No.: 201410807324.6) only published the average bactericidal rate within 5min of Escherichia coli 8099, Staphylococcus aureus ATCC6538, Candida albicans ATCC10231, Pseudomonas aeruginosa ATCC15442 and Aspergillus niger; disinfectants of quaternary ammonium salt polymers and copolymers ( Application No.: 200680039366.3) only published the average bacteriostatic ability against Escherichia coli, Staphylococcus aureus, MSRA, and vancomycin-resistant Enterococcus faecalis within 48 hours; disinfectants that can be used in high multiple dilution, preparation methods and uses (application No. : 201010216594.1) only published the average sterilization rate of Escherichia coli, Candida albicans and Staphylococcus aureus within 20min with different dilutions; Disinfectants and preparation methods in the food field (application number: 201010219496.3) only published the effects of different dilutions on Escherichia coli The average bactericidal effect within 10min; the topical antimicrobial composition (application number: 201780025348.8) only published the average bactericidal effect of different dilutions on Escherichia coli within 3h. The above-reported products containing the same ingredients as the present invention do not reflect its long-term sterilization rate effect.
本发明和目前报道的含有与本发明相同成分的产品相比主要优越性在于本发明对多种细菌病毒均有比较明显的消毒效果,杀菌杀毒起效时间短,特别的是,本发明的稳定性更好、消毒作用更持久。The main advantage of the present invention compared with the currently reported products containing the same components as the present invention is that the present invention has a relatively obvious disinfection effect on various bacteria and viruses, and the onset time of sterilization and antivirus is short. Better sex and longer lasting disinfection.
以下通过实验数据对比,说明本发明的技术优于目前已公开的与本发明相关的产品技术:Below by experimental data comparison, illustrate that the technology of the present invention is superior to the product technology related to the present invention disclosed at present:
将本发明和上述两种消毒剂以及与本发明相关的产品用灭菌硬水按照使用说明将其进行稀释成一定浓度,设置试验分组见下表1,试验结果表2和表3:The present invention and the above-mentioned two kinds of disinfectants and the product related to the present invention are diluted into a certain concentration with sterilized hard water according to the instructions for use, and the test grouping is set to see the following table 1, and the test result table 2 and table 3:
表1试验分组及稀释比例Table 1 Test grouping and dilution ratio
备注:D1产品为按照兽用消毒剂及其制备方法(申请号:200910087914.5)制备的产品;Remarks: D1 product is a product prepared according to veterinary disinfectant and its preparation method (application number: 200910087914.5);
D2产品为按照一种利用季铵盐与醇制备的新型消毒液(申请号:201410807324.6)制备的 产品;D2 product is the product prepared according to a kind of novel disinfectant (application number: 201410807324.6) prepared by utilizing quaternary ammonium salt and alcohol;
D3产品为按照季铵盐聚合物和共聚物的消毒剂(申请号:200680039366.3)制备的产品;D3 product is a product prepared according to the disinfectant of quaternary ammonium salt polymer and copolymer (application number: 200680039366.3);
D4产品为按照可高倍数稀释使用的消毒剂、制备方法和用途(申请号:201010216594.1) 制备的产品;D4 product is a product prepared according to the disinfectant, preparation method and use that can be used in high multiple dilution (application number: 201010216594.1);
D5产品为按照食品领域消毒剂及制备方法(申请号:201010219496.3)制备的产品;D5 product is a product prepared according to the disinfectant in the food field and its preparation method (application number: 201010219496.3);
D6产品为按照局部抗微生物组合物(申请号:201780025348.8)制备的产品;D6 product is a product prepared according to the topical antimicrobial composition (application number: 201780025348.8);
表2对大肠杆菌的消毒效果对比Table 2 compares the disinfection effect of Escherichia coli
注:以上结果为3次试验的平均值。Note: The above results are the average of 3 experiments.
表3对金黄色葡萄球菌的消毒效果对比Table 3 compares the disinfection effect of Staphylococcus aureus
注:以上结果为3次试验的平均值。Note: The above results are the average of 3 experiments.
试验结果表明,本发明对于大肠杆菌和金黄色葡萄球菌的杀灭效果均良好,在2.5min时对大肠杆菌和金黄色葡萄球菌的杀灭率已达到99.7%以上,且在120h时其杀灭率仍然有99.8%。苯扎氯铵溶液和复方戊二醛溶液对大肠杆菌和金黄色葡萄球菌的杀灭效果相 对较差,2.5min时均无杀灭效果,在60min时对大肠杆菌和金黄色葡萄球菌的杀灭效果最 高,随着时间的增加,杀灭效果均明显下降。D1~D6产品对大肠杆菌和金黄色葡萄球菌的 杀灭效果均明显低于本发明,且随着时间的增加,杀灭效果有下降趋势,并明显低于本发明 的杀灭效果。The test results show that the invention has good killing effects on Escherichia coli and Staphylococcus aureus, and the killing rate on Escherichia coli and Staphylococcus aureus has reached more than 99.7% at 2.5min, and it kills at 120h. The rate is still 99.8%. The killing effect of benzalkonium chloride solution and compound glutaraldehyde solution on Escherichia coli and Staphylococcus aureus is relatively poor, there is no killing effect at 2.5min, and the killing effect on Escherichia coli and Staphylococcus aureus at 60min The effect was the highest, and the killing effect decreased significantly with the increase of time. The killing effect of D1-D6 products on Escherichia coli and Staphylococcus aureus is obviously lower than that of the present invention, and with the increase of time, the killing effect has a downward trend, and is obviously lower than the killing effect of the present invention.
本发明的配方是经过筛选获得的,筛选过程如下:The formula of the present invention is obtained through screening, and the screening process is as follows:
1有效成分筛选1 Active ingredient screening
1.1配方筛选1.1 Recipe screening
通过大肠杆菌8099和金黄色葡萄球菌ATCC6538对多种单、双链季铵盐类原料进行最小抑和杀菌浓度的测定,筛选出杀菌效果最好的单、双链季铵盐。具体筛选结果见表4-1。The minimum inhibitory and bactericidal concentrations of various single- and double-chain quaternary ammonium salts were determined by Escherichia coli 8099 and Staphylococcus aureus ATCC6538, and the single- and double-chain quaternary ammonium salts with the best bactericidal effect were screened. The specific screening results are shown in Table 4-1.
表4-1季铵盐类消毒剂的最小抑菌、杀菌浓度(MIC/MBC)的测定结果Table 4-1 Determination results of minimum inhibitory and bactericidal concentrations (MIC/MBC) of quaternary ammonium salt disinfectants
注:以上结果为3次试验的平均值。试验条件均为20±1℃,MBC组作用时间为5min。Note: The above results are the average of 3 experiments. The experimental conditions were 20±1℃, and the action time of MBC group was 5min.
阴性对照组无菌生长。The negative control group grew aseptically.
结果表明:单链季铵盐中苯扎氯铵对于大肠杆菌最小抑菌浓度为0.004μg/ml,最小杀菌浓度为0.061μg/ml,抑菌、杀菌效果效果均最好,苯扎氯铵对于金黄色葡萄球菌最小抑菌浓度为0.001μg/ml,最小杀菌浓度为0.015μg/ml,抑菌、杀菌效果效果均最好;双链季铵盐中癸甲氯铵对于大肠杆菌最小抑菌浓度为0.004μg/ml,最小杀菌浓度为0.030μg/ml,抑 菌、杀菌效果效果均最好,癸甲氯铵对于金黄色葡萄球菌最小抑菌浓度为0.001μg/ml,最小 杀菌浓度为0.030μg/ml,抑菌、杀菌效果效果均最好。因此决定选择苯扎氯铵、癸甲氯铵作 为本发明的复方成分。The results showed that the minimum inhibitory concentration of benzalkonium chloride for Escherichia coli was 0.004μg/ml, and the minimum bactericidal concentration was 0.061μg/ml. The bacteriostatic and bactericidal effects were the best. The minimum inhibitory concentration of Staphylococcus aureus is 0.001μg/ml, and the minimum bactericidal concentration is 0.015μg/ml, and the bacteriostatic and bactericidal effects are the best; the double-chain quaternary ammonium salt of decamethonium chloride has the minimum inhibitory concentration on Escherichia coli The minimum bactericidal concentration is 0.004μg/ml, the minimum bactericidal concentration is 0.030μg/ml, and the antibacterial and bactericidal effects are the best. /ml, the antibacterial and bactericidal effects are the best. Therefore decided to select benzalkonium chloride, decyl ammonium chloride as the compound ingredients of the present invention.
1.2比例筛选1.2 Proportional screening
以兽用消毒剂指示菌大肠杆菌8099和金黄色葡萄球菌ATCC6538为试验菌株进 行联合药敏试验。运用棋盘法,使用96孔无菌微孔板,根据测得单双链季铵盐的MIC值, 分别以两药的9倍MIC、3倍MIC、1倍MIC、1/3MIC、1/9MIC进行联合。每菌株重复棋 盘试验3次。试验结果以部分抑菌浓度(FIC)指数作为联合药敏试验的判断依据。The veterinary disinfectant indicator bacteria Escherichia coli 8099 and Staphylococcus aureus ATCC6538 were used as test strains to carry out the combined drug susceptibility test. Using the checkerboard method, using a 96-well sterile microplate, according to the measured MIC values of single- and double-chain quaternary ammonium salts, 9 times MIC, 3 times MIC, 1 times MIC, 1/3 MIC, 1/9 MIC of the two drugs were used respectively. Make a union. The checkerboard test was repeated 3 times for each strain. The test results were based on the partial inhibitory concentration (FIC) index as the judgment basis for the combined drug susceptibility test.
结果判别:根据联合药敏与单独药敏的抑菌情况,以部分抑菌浓度指数(FIC) 作为判断依据。Result judgment: According to the antibacterial situation of the combined drug susceptibility and the single drug susceptibility, the partial inhibitory concentration index (FIC) was used as the judgment basis.
注:当FIC≤0.5时,表示协同作用;Note: When FIC≤0.5, it means synergy;
当0.5<FIC≤1时,表示相加作用;When 0.5<FIC≤1, it means additive effect;
当1<FIC≤2时,表示无关作用;When 1<FIC≤2, it means irrelevant effect;
当FIC>2时,表示拮抗作用。When FIC>2, antagonism is indicated.
表4-2苯扎氯铵与癸甲氯铵对大肠杆菌(8099)的联合药敏试验结果Table 4-2 Results of the combined drug susceptibility test of benzalkonium chloride and decamethylammonium chloride to Escherichia coli (8099)
注:以上结果为3次试验的平均值。试验条件均为20±1℃。阳性对照组混浊,阴性对 照组无菌生长。Note: The above results are the average of 3 experiments. The test conditions are all 20±1℃. The positive control group was cloudy, and the negative control group grew sterile.
苯扎氯铵-癸甲氯铵(1:2):FIC=0.0004/0.004+0.001/0.004=0.35,协同作用Benzalkonium chloride-decamethonium chloride (1:2): FIC=0.0004/0.004+0.001/0.004=0.35, synergistic effect
苯扎氯铵-癸甲氯铵(1:1):FIC=0.001/0.004+0.001/0.004=0.5,协同作用Benzalkonium chloride-decamethonium chloride (1:1): FIC=0.001/0.004+0.001/0.004=0.5, synergistic effect
苯扎氯铵-癸甲氯铵(2:1):FIC=0.001/0.004+0.0004/0.004=0.35,协同作用Benzalkonium chloride-decamethonium chloride (2:1): FIC=0.001/0.004+0.0004/0.004=0.35, synergistic effect
表4-3苯扎氯铵与癸甲氯铵对金黄色葡萄球菌(ATCC 6538)的联合药敏试验结果Table 4-3 The results of the combined drug susceptibility test of benzalkonium chloride and decamethonium chloride against Staphylococcus aureus (ATCC 6538)
注:以上结果为3次试验的平均值。试验条件均为20±1℃。阳性对照组混浊,阴性对 照组无菌生长。Note: The above results are the average of 3 experiments. The test conditions are all 20±1℃. The positive control group was cloudy, and the negative control group grew sterile.
苯扎氯铵-癸甲氯铵(1:2):FIC=0.0004/0.004+0.001/0.004=0.35,协同作用Benzalkonium chloride-decamethonium chloride (1:2): FIC=0.0004/0.004+0.001/0.004=0.35, synergistic effect
苯扎氯铵-癸甲氯铵(1:1):FIC=0.001/0.004+0.001/0.004=0.5,协同作用Benzalkonium chloride-decamethonium chloride (1:1): FIC=0.001/0.004+0.001/0.004=0.5, synergistic effect
苯扎氯铵-癸甲氯铵(2:1):FIC=0.001/0.004+0.0004/0.004=0.35,协同作用Benzalkonium chloride-decamethonium chloride (2:1): FIC=0.001/0.004+0.0004/0.004=0.35, synergistic effect
结果表明:通过对单个季铵盐药物进行MIC/MBC筛选,筛选出抑菌、杀菌效果 最好的苯扎氯铵和癸甲氯铵作为配方的主要成分。通过对消毒剂指示菌大肠杆菌8099和金 黄色葡萄球菌ATCC6538进行联合药敏试验得出苯扎氯铵、癸甲氯铵的比值在2:1-1:2之间时,两药呈协同作用,抑菌效果最强,综合考虑,确定本发明苯扎氯铵、癸甲氯铵的比值为1:1.5。The results showed that: by MIC/MBC screening of a single quaternary ammonium salt drug, benzalkonium chloride and decamethylammonium chloride with the best antibacterial and bactericidal effects were screened out as the main ingredients of the formula. Through the combined drug susceptibility test of the disinfectant indicator bacteria Escherichia coli 8099 and Staphylococcus aureus ATCC6538, it was found that when the ratio of benzalkonium chloride and decamethonium chloride was between 2:1-1:2, the two drugs showed a synergistic effect , the bacteriostatic effect is the strongest, comprehensive consideration, it is determined that the ratio of benzalkonium chloride of the present invention and decamethylammonium chloride is 1:1.5.
2稳定剂种类和浓度的选择2 Selection of stabilizer types and concentrations
季铵盐类消毒剂都是阳离子表面活性剂,因此不能和阴离子型表面活性剂合用,例如肥皂、卵磷脂、洗衣粉、吐温-80,另有些物质和季铵盐类消毒剂有拮抗作用,例如碘、碘化钾、蛋白银、水杨酸、氯化汞、过氧化物、钙、镁、铁、铝等金属离子有拮抗作用。Quaternary ammonium salt disinfectants are all cationic surfactants, so they cannot be used in combination with anionic surfactants, such as soap, lecithin, washing powder, Tween-80, and some other substances have antagonistic effects with quaternary ammonium salt disinfectants. , For example, iodine, potassium iodide, protein silver, salicylic acid, mercuric chloride, peroxide, calcium, magnesium, iron, aluminum and other metal ions have antagonistic effects.
稳定剂来源:Source of stabilizer:
EDTA·2Na:购于南京化学试剂股份有限公司,分析纯;EDTA·2Na: purchased from Nanjing Chemical Reagent Co., Ltd., analytically pure;
聚乙烯醇:购于江西阿尔法高科药业有限公司,分析纯;Polyvinyl alcohol: purchased from Jiangxi Alpha Hi-Tech Pharmaceutical Co., Ltd., analytically pure;
Provichem 2203:购于普威伦公司,医药级,为一种新型的共聚型稳定剂,未见 有报道用于消毒领域;Provichem 2203: purchased from Provien Company, pharmaceutical grade, is a new type of copolymerization stabilizer, and has not been reported to be used in the field of disinfection;
2.1不同种类稳定剂浓度的筛选2.1 Screening of different types of stabilizer concentrations
试验条件建立:选取EDTA·2Na、聚乙烯醇、Provichem 2203三种常用稳定剂, 设置不同浓度,制备处方制剂,考察各浓度下制剂的性状、pH值、澄清度、含量测定和抑 菌效果,筛选出最优的稳定剂种类和浓度。具体筛选结果见表4-4~4-6。Establishment of test conditions: Three commonly used stabilizers, EDTA·2Na, polyvinyl alcohol, and Provichem 2203, were selected, and different concentrations were set to prepare prescription preparations. The optimal type and concentration of stabilizer were screened out. The specific screening results are shown in Tables 4-4 to 4-6.
表4-4 EDTA·2Na作为稳定剂的性质表征Table 4-4 Characterization of EDTA·2Na as Stabilizer
表4-5聚乙烯醇作为稳定剂的性质表征Table 4-5 Characterization of polyvinyl alcohol as stabilizer
表4-6 Provichem 2203作为稳定剂的性质表征Table 4-6 Characterization of Provichem 2203 as stabilizer
以上试验结果表明,不同种类的稳定剂对本发明的性状、pH值、澄清度及主药 成分含量没有明显影响,然后我们采用药敏片法,通过测量不同稳定剂浓度和种类的本发明对金黄色葡萄球菌、大肠杆菌和白色念珠菌抑菌圈直径的大小,试验数据采用Excel进行收集,SPSS 17.0软件进行方差分析,结果用表示,用字母标记法标示,出现P<0.05 表示差异显著;P>0.05表示差异不显著,以期选出最佳的稳定剂种类和浓度。The above test results show that different kinds of stabilizers have no obvious effect on the properties, pH value, clarity and main drug component content of the present invention. The diameter of the inhibition zone of Staphylococcus aureus, Escherichia coli and Candida albicans, the test data were collected by Excel, and SPSS 17.0 software was used for variance analysis. It is indicated by letter notation, P<0.05 means significant difference; P>0.05 means no significant difference, in order to select the best stabilizer type and concentration.
我们首先分别对EDTA·2Na、聚乙烯醇、Provichem 2203三种稳定剂的最佳浓度数据进行分析,具体结果见表4-7~4-9。We first analyzed the optimal concentration data of EDTA·2Na, polyvinyl alcohol, and Provichem 2203, respectively. The specific results are shown in Tables 4-7 to 4-9.
表4-7不同浓度的EDTA·2Na对金黄色葡萄球菌、大肠杆菌、白色念珠菌的 抑菌效果The bacteriostatic effect of table 4-7 different concentrations of EDTA·2Na on Staphylococcus aureus, Escherichia coli and Candida albicans
注:同一列标不同小写字母表示差异显著,P<0.05;不标或者标相同字母表示差异不显著, P>0.05。Note: Different lowercase letters in the same column indicate significant difference, P < 0.05; no mark or the same letter indicates no significant difference, P > 0.05.
由上述结果可知:It can be seen from the above results that:
金黄色葡萄球菌:所考察的EDTA·2Na浓度中,当所添加的浓度为0.006%时, 本发明对金黄色葡萄球菌的抑菌效果较好,且显著优于其他浓度的抑菌效果。因此,选择向本发明中加入0.006%的EDTA·2Na。Staphylococcus aureus: In the investigated EDTA·2Na concentration, when the added concentration is 0.006%, the present invention has better bacteriostatic effect on Staphylococcus aureus, and is significantly better than the bacteriostatic effect of other concentrations. Therefore, 0.006% EDTA·2Na was chosen to be added to the present invention.
大肠杆菌:所考察的EDTA·2Na浓度中,当所添加的浓度为0.006%时,本发明 对大肠杆菌的抑菌效果较好,且显著优于其他浓度的抑菌效果。因此,选择向本发明中加入0.006%的EDTA·2Na。Escherichia coli: In the investigated EDTA·2Na concentration, when the added concentration is 0.006%, the present invention has better bacteriostatic effect on Escherichia coli, and is significantly better than the bacteriostatic effect of other concentrations. Therefore, 0.006% EDTA·2Na was chosen to be added to the present invention.
白色念珠菌:所考察的EDTA·2Na浓度中,当所添加的浓度为0.002%时,本发 明对白色念珠菌的抑菌效果较好,且显著优于其他浓度的抑菌效果。当所添加的浓度为0.006%时,其对白色念珠菌的抑菌效果仅次于浓度为0.002%的本发明,且显著优于其他浓 度的抑菌效果。Candida albicans: in the investigated EDTA·2Na concentration, when the added concentration is 0.002%, the present invention has better bacteriostatic effect on Candida albicans, and is significantly better than the bacteriostatic effect of other concentrations. When the added concentration is 0.006%, its bacteriostatic effect on Candida albicans is second only to that of the present invention with a concentration of 0.002%, and is significantly better than the bacteriostatic effect of other concentrations.
该消毒剂主要作用是针对多种菌,而不是单纯的针对某一种病原菌。因此,综上所述,暂定选择向本发明中加入0.006%的EDTA·2Na。The main function of the disinfectant is to target a variety of bacteria, rather than simply targeting a certain pathogen. Therefore, in view of the above, it is tentatively chosen to add 0.006% EDTA·2Na to the present invention.
表4-8不同浓度的聚乙烯醇对金黄色葡萄球菌、大肠杆菌、白色念珠菌的抑菌效果Table 4-8 The antibacterial effect of different concentrations of polyvinyl alcohol on Staphylococcus aureus, Escherichia coli and Candida albicans
注:同一列标不同小写字母表示差异显著,P<0.05;不标或者标相同字母表示差异不显著, P>0.05。Note: Different lowercase letters in the same column indicate significant difference, P < 0.05; no mark or the same letter indicates no significant difference, P > 0.05.
由上述结果可知:It can be seen from the above results that:
金黄色葡萄球菌:所考察的聚乙烯醇浓度中,当所添加的浓度为0.001%时,本发明对金黄色葡萄球菌的抑菌效果较好,且显著优于其他浓度的抑菌效果。因此,选择向本发明中加入0.001%的聚乙烯醇。Staphylococcus aureus: In the investigated concentration of polyvinyl alcohol, when the added concentration is 0.001%, the present invention has better bacteriostatic effect on Staphylococcus aureus, and is significantly better than the bacteriostatic effect of other concentrations. Therefore, 0.001% polyvinyl alcohol was chosen to be added to the present invention.
大肠杆菌:所考察的聚乙烯醇浓度中,当所添加的浓度为0.001%和0.002%时,本发明对大肠杆菌的抑菌效果较好,且显著优于其他浓度的抑菌效果。因此,可向本发明中加入0.001%或0.002%的聚乙烯醇。Escherichia coli: Among the polyvinyl alcohol concentrations investigated, when the added concentrations are 0.001% and 0.002%, the present invention has better bacteriostatic effect on Escherichia coli, and is significantly better than other concentrations. Therefore, 0.001% or 0.002% polyvinyl alcohol can be added to the present invention.
白色念珠菌:所考察的聚乙烯醇浓度中,当所添加的浓度为0.001%、0.002%、0.005%和0.010%时,本发明对白色念珠菌的抑菌效果相当,且显著优于浓度为0.020%和未 添加聚乙烯醇的抑菌效果。Candida albicans: In the investigated concentration of polyvinyl alcohol, when the added concentrations are 0.001%, 0.002%, 0.005% and 0.010%, the antibacterial effect of the present invention on Candida albicans is equivalent, and significantly better than the concentration of 0.020 % and the bacteriostatic effect of no added polyvinyl alcohol.
综上所述,可暂定向本发明中加入0.001%的聚乙烯醇,以使本发明的抑菌效果达到较优水平。To sum up, 0.001% of polyvinyl alcohol can be temporarily added to the present invention to make the antibacterial effect of the present invention reach a better level.
表4-9不同浓度的Provichem 2203对金黄色葡萄球菌、大肠杆菌、白色念珠菌 的抑菌效果Table 4-9 The antibacterial effect of different concentrations of Provichem 2203 on Staphylococcus aureus, Escherichia coli and Candida albicans
注:同一列标不同小写字母表示差异显著,P<0.05;不标或者标相同字母表示差异不显著, P>0.05。Note: Different lowercase letters in the same column indicate significant difference, P < 0.05; no mark or the same letter indicates no significant difference, P > 0.05.
由上述结果可知:It can be seen from the above results that:
金黄色葡萄球菌:所考察的Provichem 2203浓度中,当所添加的浓度为0.005%和0.002%时,本发明对金黄色葡萄球菌的抑菌效果较好,且显著优于其他浓度的抑菌效果。 因此,可选择向本发明中加入0.005%和0.002%的Provichem 2203。Staphylococcus aureus: Among the investigated concentrations of Provichem 2203, when the added concentrations are 0.005% and 0.002%, the present invention has better bacteriostatic effect on Staphylococcus aureus, and is significantly better than other concentrations. Therefore, 0.005% and 0.002% of Provichem 2203 may optionally be added to the present invention.
大肠杆菌:所考察的Provichem 2203浓度中,当所添加的浓度为0.005%和0.002% 时,本发明对大肠杆菌的抑菌效果较好,且显著优于其他浓度的抑菌效果。因此,可向本发 明中加入0.005%和0.002%的Provichem 2203。Escherichia coli: Among the investigated concentrations of Provichem 2203, when the added concentrations are 0.005% and 0.002%, the present invention has better bacteriostatic effect on Escherichia coli, and is significantly better than other concentrations. Therefore, 0.005% and 0.002% of Provichem 2203 can be added to the present invention.
白色念珠菌:所考察的Provichem 2203浓度中,当所添加的浓度为0.002%时,本发明对白色念珠菌的抑菌效果较好,且显著优于其他浓度的抑菌效果。因此,可向本发明中加入0.005%的Provichem 2203。Candida albicans: Among the investigated concentrations of Provichem 2203, when the added concentration is 0.002%, the present invention has better bacteriostatic effect on Candida albicans, and is significantly better than the bacteriostatic effect of other concentrations. Therefore, 0.005% of Provichem 2203 can be added to the present invention.
综上所述,可向本发明中加入0.002%的Provichem 2203,以使本发明的抑菌效果达到较优水平。To sum up, 0.002% of Provichem 2203 can be added to the present invention to make the antibacterial effect of the present invention reach a better level.
2.2稳定剂种类的筛选2.2 Screening of stabilizer types
将上述所筛选出来的最优浓度的EDTA·2Na、聚乙烯醇、Provichem 2203对金黄色葡萄球菌、大肠杆菌、白色念珠菌的抑菌效果两两组合进行比较,以期筛选出最优的稳定剂种类。Compare the bacteriostatic effects of EDTA·2Na, polyvinyl alcohol, and Provichem 2203 of the above-selected optimal concentrations on Staphylococcus aureus, Escherichia coli, and Candida albicans, in order to screen out the optimal stabilizer. type.
表4-10不同比例的稳定剂对金黄色葡萄球菌、大肠杆菌、白色念珠菌的抑菌效果Table 4-10 The antibacterial effect of different proportions of stabilizers on Staphylococcus aureus, Escherichia coli and Candida albicans
注:同一列标不同小写字母表示差异显著,P<0.05;不标或者标相同字母表示差异不显著, P>0.05。Note: Different lowercase letters in the same column indicate significant difference, P < 0.05; no mark or the same letter indicates no significant difference, P > 0.05.
由上述结果可知,EDTA·2Na:Provichem 2203=3:1时对金黄色葡萄球菌、大肠杆菌和白色念珠菌均有较好的抑菌效果,且显著优于其他组合的稳定剂。因此,最终处方中选择EDTA·2Na:Provichem 2203=3:1作为本发明的最佳稳定剂种类和浓度,即EDTA·2Na浓度为0.006%,Provichem 2203浓度为0.002%。It can be seen from the above results that EDTA·2Na:Provichem 2203=3:1 has good bacteriostatic effect on Staphylococcus aureus, Escherichia coli and Candida albicans, and is significantly better than other combinations of stabilizers. Therefore, EDTA·2Na:Provichem 2203=3:1 was selected as the optimum stabilizer type and concentration in the present invention, that is, the concentration of EDTA·2Na was 0.006%, and the concentration of Provichem 2203 was 0.002%.
3pH值的选择3 The choice of pH
试验条件建立:按照本发明处方配制5份制剂样品,使用氢氧化钠或盐酸试液分别调节pH至2、4、6、8、10。考察各pH值制剂的性状、澄清度、是否析出和抑菌效果, 以期筛选出最佳pH值。Establishment of test conditions: 5 preparation samples were prepared according to the prescription of the present invention, and the pH was adjusted to 2, 4, 6, 8, and 10 with sodium hydroxide or hydrochloric acid test solution, respectively. The properties, clarity, precipitation and bacteriostatic effect of each pH value preparation were investigated in order to screen out the best pH value.
表4-11不同pH值的本发明性质考察Table 4-11 Investigation on the properties of the present invention with different pH values
取每个pH条件下包装完整的供试品50ml各5份,采用药敏片法,通过测量不同 pH值的本发明对金黄色葡萄球菌、大肠杆菌和白色念珠菌抑菌圈直径的大小,试验数据采 用Excel进行收集,SPSS17.0软件进行方差分析,结果用表示,用字母标记法标示, 出现P<0.05表示差异显著;P>0.05表示差异不显著,以期选出最佳的pH值。具体结果 见表4-12。Take 5 parts of 50ml of the complete test sample packaged under each pH condition, adopt the drug sensitive tablet method, and measure the diameter of the inhibition zone of Staphylococcus aureus, Escherichia coli and Candida albicans of the present invention with different pH values, The experimental data were collected using Excel, and SPSS17.0 software was used for variance analysis. Indicated by letter notation, P<0.05 means significant difference; P>0.05 means no significant difference, in order to select the best pH value. The specific results are shown in Table 4-12.
表4-12不同pH值对金黄色葡萄球菌、大肠杆菌、白色念珠菌的抑菌效果Table 4-12 Bacteriostatic effect of different pH values on Staphylococcus aureus, Escherichia coli and Candida albicans
注:同一列标不同小写字母表示差异显著,P<0.05;不标或者标相同字母表示差异不显著, P>0.05。Note: Different lowercase letters in the same column indicate significant difference, P < 0.05; no mark or the same letter indicates no significant difference, P > 0.05.
由上述结果可知:It can be seen from the above results that:
金黄色葡萄球菌:所考察的pH值中,pH值8、10组的抑菌效果最好,且显著高 于pH值2、4、6组的抑菌效果。因此,pH值为8~10时,本发明对金黄色葡萄球菌的抑 菌效果较好。Staphylococcus aureus: Among the pH values investigated, the bacteriostatic effects of pH 8 and 10 groups were the best, and were significantly higher than those of pH 2, 4, and 6 groups. Therefore, when the pH value is 8-10, the present invention has better bacteriostatic effect on Staphylococcus aureus.
大肠杆菌:所考察的pH值中,pH值8组的抑菌效果最好,其次为pH值10组, 且显著高于pH值2、4、6,组。因此,pH值为8~10时,本发明对大肠杆菌的抑菌效果较 好。Escherichia coli: Among the pH values investigated, pH 8 group had the best bacteriostatic effect, followed by pH 10 group, which was significantly higher than pH 2, 4, and 6 groups. Therefore, when the pH value is 8-10, the antibacterial effect of the present invention on Escherichia coli is better.
白色念珠菌:所考察的pH值中,pH值8组的抑菌效果最好,其次为pH值10 组,且显著高于pH值2、4、6组。因此,pH值为8~10时,本发明对白色念珠菌的抑菌 效果较好。Candida albicans: Among the pH values investigated, pH 8 group had the best bacteriostatic effect, followed by pH 10 group, which was significantly higher than pH 2, 4, and 6 groups. Therefore, when the pH value is 8-10, the antibacterial effect of the present invention on Candida albicans is better.
综上所述,考虑到本发明的作用主要用于杀灭细菌、真菌等微生物,因此本发明的pH值定为8~10,且最优选pH值为8。To sum up, considering that the function of the present invention is mainly used to kill microorganisms such as bacteria and fungi, the pH value of the present invention is set at 8-10, and the pH value is most preferably 8.
具体实施方式Detailed ways
实施例一Example 1
将30g十二烷基(50%C14,40%C12,10%C16)二甲基苄基氯化铵原料药与适量 纯化水混合,于70℃加热使其完全熔融成可流动状态;依次加入60g双癸基二甲基氯化铵,0.006g乙二胺四乙酸二钠,0.002g Provichem 2203于搅拌器上搅拌均匀;用酸碱调节剂调节 本环境消毒用药物组合物的pH值为8~10,纯化水定容至1L即得一种环境消毒用药物组合物。Mix 30 g of dodecyl (50% C 14 , 40% C 12 , 10% C 16 ) dimethylbenzyl ammonium chloride bulk drug with an appropriate amount of purified water, and heat it at 70°C to melt it completely into a flowable state ; Add 60g bis-decyl dimethyl ammonium chloride successively, 0.006g disodium EDTA, 0.002g Provichem 2203 and stir on the stirrer; Adjust the pH of the pharmaceutical composition for environmental disinfection with an acid-base regulator The value is 8-10, and the purified water is adjusted to 1L to obtain a pharmaceutical composition for environmental disinfection.
实施例二Embodiment 2
将50g十二烷基(50%C14,40%C12,10%C16)二甲基苄基氯化铵原料药与适量 纯化水混合,于70℃加热使其完全熔融成可流动状态;依次加入75g双癸基二甲基氯化铵,0.015g乙二胺四乙酸二钠,0.008g Provichem 2203于搅拌器上搅拌均匀;用酸碱调节剂调节 本环境消毒用药物组合物的pH值为8~10,纯化水定容至1L即得一种环境消毒用药物组合物。Mix 50 g of dodecyl (50% C 14 , 40% C 12 , 10% C 16 ) dimethylbenzyl ammonium chloride bulk drug with an appropriate amount of purified water, and heat it at 70°C to melt it completely into a flowable state ; Add 75g of bis-decyl dimethyl ammonium chloride, 0.015g of disodium EDTA, 0.008g of Provichem 2203 and stir on the stirrer successively; Adjust the pH of the pharmaceutical composition for environmental disinfection with an acid-base regulator The value is 8-10, and the purified water is adjusted to 1L to obtain a pharmaceutical composition for environmental disinfection.
实施例三Embodiment 3
将100g十二烷基(50%C14,40%C12,10%C16)二甲基苄基氯化铵原料药与适量 纯化水混合,于70℃加热使其完全熔融成可流动状态;依次加入150g双癸基二甲基氯化铵,0.06g乙二胺四乙酸二钠,0.02g Provichem 2203于搅拌器上搅拌均匀;用酸碱调节剂调节本 环境消毒用药物组合物的pH值为8~10,纯化水定容至1L即得一种环境消毒用药物组合物。Mix 100 g of dodecyl (50% C 14 , 40% C 12 , 10% C 16 ) dimethylbenzyl ammonium chloride raw material drug with an appropriate amount of purified water, and heat at 70°C to completely melt it into a flowable state ; Add 150g of bisdecyl dimethyl ammonium chloride successively, 0.06g of disodium EDTA, 0.02g of Provichem 2203 and stir on the stirrer; Adjust the pH of the pharmaceutical composition for environmental disinfection with an acid-base regulator The value is 8-10, and the purified water is adjusted to 1L to obtain a pharmaceutical composition for environmental disinfection.
实施例四Embodiment 4
将100g十二烷基(50%C14,40%C12,10%C16)二甲基苄基氯化铵原料药与适量 纯化水混合,于70℃加热使其完全熔融成可流动状态;依次加入200g双癸基二甲基氯化铵,0.3g乙二胺四乙酸二钠,0.2g Provichem 2203于搅拌器上搅拌均匀;用酸碱调节剂调节本环 境消毒用药物组合物的pH值为8~10,纯化水定容至1L即得一种环境消毒用药物组合物。Mix 100 g of dodecyl (50% C 14 , 40% C 12 , 10% C 16 ) dimethylbenzyl ammonium chloride raw material drug with an appropriate amount of purified water, and heat at 70°C to completely melt it into a flowable state ; Add 200g bisdecyl dimethyl ammonium chloride successively, 0.3g disodium EDTA, 0.2g Provichem 2203 and stir on the stirrer; Adjust the pH of the pharmaceutical composition for environmental disinfection with an acid-base regulator The value is 8-10, and the purified water is adjusted to 1L to obtain a pharmaceutical composition for environmental disinfection.
实施例五Embodiment 5
将150g十二烷基(50%C14,40%C12,10%C16)二甲基苄基氯化铵原料药与适量 纯化水混合,于70℃加热使其完全熔融成可流动状态;依次加入200g双癸基二甲基氯化铵,0.2g乙二胺四乙酸二钠,0.08g Provichem 2203于搅拌器上搅拌均匀;用酸碱调节剂调节本 环境消毒用药物组合物的pH值为8~10,纯化水定容至1L即得一种环境消毒用药物组合物。Mix 150 g of dodecyl (50% C 14 , 40% C 12 , 10% C 16 ) dimethylbenzyl ammonium chloride raw material drug with an appropriate amount of purified water, and heat at 70°C to completely melt into a flowable state ; Add 200g of bisdecyl dimethyl ammonium chloride successively, 0.2g of disodium EDTA, 0.08g of Provichem 2203 and stir on the stirrer; Adjust the pH of the pharmaceutical composition for environmental disinfection with an acid-base regulator The value is 8-10, and the purified water is adjusted to 1L to obtain a pharmaceutical composition for environmental disinfection.
实施例六Embodiment 6
将200g十二烷基(50%C14,40%C12,10%C16)二甲基苄基氯化铵原料药与适量 纯化水混合,于70℃加热使其完全熔融成可流动状态;依次加入250g双癸基二甲基氯化铵,0.006g乙二胺四乙酸二钠,0.004g Provichem 2203于搅拌器上搅拌均匀;用酸碱调节剂调节 本环境消毒用药物组合物的pH值为8~10,纯化水定容至1L即得一种环境消毒用药物组合物。Mix 200 g of dodecyl (50% C 14 , 40% C 12 , 10% C 16 ) dimethylbenzyl ammonium chloride raw material with an appropriate amount of purified water, and heat it at 70°C to completely melt it into a flowable state ; Add 250g of bis-decyl dimethyl ammonium chloride, 0.006g of disodium EDTA, 0.004g of Provichem 2203 and stir on the stirrer successively; Adjust the pH of the pharmaceutical composition for environmental disinfection with an acid-base regulator The value is 8-10, and the purified water is adjusted to 1L to obtain a pharmaceutical composition for environmental disinfection.
实施例七Embodiment 7
将200g十二烷基(50%C14,40%C12,10%C16)二甲基苄基氯化铵原料药与适量 纯化水混合,于70℃加热使其完全熔融成可流动状态;依次加入300g双癸基二甲基氯化铵,0.15g乙二胺四乙酸二钠,0.1g Provichem 2203于搅拌器上搅拌均匀;用酸碱调节剂调节本 环境消毒用药物组合物的pH值为8~10,纯化水定容至1L即得一种环境消毒用药物组合物。Mix 200 g of dodecyl (50% C 14 , 40% C 12 , 10% C 16 ) dimethylbenzyl ammonium chloride raw material with an appropriate amount of purified water, and heat it at 70°C to completely melt it into a flowable state ; Add 300g of bisdecyl dimethyl ammonium chloride successively, 0.15g of disodium EDTA, 0.1g of Provichem 2203 and stir on the stirrer; Adjust the pH of the pharmaceutical composition for environmental disinfection with an acid-base regulator The value is 8-10, and the purified water is adjusted to 1L to obtain a pharmaceutical composition for environmental disinfection.
实施例一至实施例七之一所述各组分用量按照相同比例增加或减少,所得各组分的重量份数关系均属于本发明的保护范围。The dosage of each component described in one of Examples 1 to 7 is increased or decreased according to the same proportion, and the relationship between the weight and the fraction of each component obtained belongs to the protection scope of the present invention.
实施例八Embodiment 8
稳定性试验Stability test
试验样品为实施例一、实施例二、实施例三制得的一种环境消毒用药物组合物;检测项目包括性状、pH值、澄清度、杀灭微生物效果、含量。The test sample is a pharmaceutical composition for environmental disinfection prepared in Example 1, Example 2, and Example 3; the test items include properties, pH value, clarity, microbial killing effect, and content.
加速试验accelerated test
将实施例一、实施例二、实施例三制得的三批样品在40±2℃、相对湿度65±5%条件下放置六个月,于第0、1、2、3、6月末取样,考察性状、pH值、澄清度、杀灭微生 物效果、含量等项目,与0天的检测结果对比,结果见下表1。The three batches of samples prepared in Example 1, Example 2, and Example 3 were placed under the conditions of 40±2°C and 65±5% relative humidity for six months, and samples were taken at the end of the 0th, 1st, 2nd, 3rd, and 6th months. , investigate the properties, pH value, clarity, microbial killing effect, content and other items, and compare with the test results of 0 days. The results are shown in Table 1 below.
长期试验long term trial
将实施例一、实施例二、实施例三制得的三批样品在25±2℃、相对湿度60±10%条件下放置,于第0、3、6、9、12、18、24月取样,考察性状、pH值、澄清度、杀灭微生 物效果、含量等项目,与0天的检测结果对比,结果见下表2。The three batches of samples prepared in Example 1, Example 2 and Example 3 were placed under the conditions of 25±2°C and relative humidity of 60±10%. Sampling was carried out to investigate the properties, pH value, clarity, microbial killing effect, content and other items, and compared with the test results of 0 days, the results are shown in Table 2 below.
表1三批样品加速试验结果Table 1 Accelerated test results of three batches of samples
注:a表示杀菌率;Note: a represents the sterilization rate;
b表示十二烷基(50%C14,40%C12,10%C16)二甲基苄基氯化铵;b represents dodecyl (50% C 14 , 40% C 12 , 10% C 16 ) dimethylbenzylammonium chloride;
c表示双癸基二甲基氯化铵c stands for bisdecyldimethylammonium chloride
表2三批样品长期试验结果Table 2 Long-term test results of three batches of samples
注:a表示杀菌率;Note: a represents the sterilization rate;
b表示十二烷基(50%C14,40%C12,10%C16)二甲基苄基氯化铵;b represents dodecyl (50% C 14 , 40% C 12 , 10% C 16 ) dimethylbenzylammonium chloride;
c表示双癸基二甲基氯化铵c stands for bisdecyldimethylammonium chloride
由加速试验及长期试验结果可知,由实施例一、实施例二、实施例三制得的三 批样品在40±2℃、RH65±5%条件下放置6个月以及在25±2℃、RH60±10%条件下放置36 个月,样品的外观性状无明显变化,pH、澄清度均符合规定,含量变化不显著,杀灭微生 物效果无显著性变化,表明该发明制得的一种环境消毒用药物组合物质量稳定性高,杀菌率 稳定,杀菌消毒作用时间长。It can be seen from the accelerated test and long-term test results that the three batches of samples prepared by Example 1, Example 2 and Example 3 were placed under the conditions of 40±2°C, RH65±5% for 6 months and at 25±2°C, After being placed for 36 months under the condition of RH60±10%, the appearance of the sample has no obvious change, the pH and clarity are in compliance with the regulations, the content change is not significant, and the killing effect of microorganisms has no significant change, indicating that the invention made an environment. The medicinal composition for disinfection has high quality stability, stable sterilization rate and long sterilization and disinfection time.
实施例一至实施例七之一以及实施例一至实施例七之一所述各组分用量按照相同比例增加或减少所得到的组合,所做的稳定性试验以及结果均属于本发明的保护范围。The combination obtained by increasing or decreasing the dosage of each component described in one of the first to seventh embodiments and one of the first to seventh embodiments, the stability test and the results are all within the protection scope of the present invention.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010198458.8A CN111436429A (en) | 2020-03-20 | 2020-03-20 | Pharmaceutical composition for environmental disinfection and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010198458.8A CN111436429A (en) | 2020-03-20 | 2020-03-20 | Pharmaceutical composition for environmental disinfection and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111436429A true CN111436429A (en) | 2020-07-24 |
Family
ID=71629447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010198458.8A Pending CN111436429A (en) | 2020-03-20 | 2020-03-20 | Pharmaceutical composition for environmental disinfection and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111436429A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112042645A (en) * | 2020-08-22 | 2020-12-08 | 西北工业大学 | A kind of compound quaternary ammonium salt disinfectant |
| CN112262846A (en) * | 2020-11-13 | 2021-01-26 | 中国科学院武汉病毒研究所 | Object surface disinfectant for high-grade biosafety laboratory and preparation method thereof |
| CN112655704A (en) * | 2020-12-23 | 2021-04-16 | 合肥天一生物技术研究所有限责任公司 | Quaternary ammonium salt composite disinfectant |
| CN112690277A (en) * | 2020-12-25 | 2021-04-23 | 广州艺境环保科技有限公司 | Sterilization material suitable for indoor space of hospital school and preparation method thereof |
| CN112970752A (en) * | 2021-03-01 | 2021-06-18 | 中国日用化学研究院有限公司 | Environment-friendly efficient surface disinfectant and preparation method thereof |
| WO2022135505A1 (en) * | 2020-12-23 | 2022-06-30 | 北京瞬行生物科技有限公司 | Composite quaternary ammonium salt disinfectant and preparation method therefor |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4320147A (en) * | 1980-05-09 | 1982-03-16 | Lonza Inc. | Disinfectant composition and the use thereof |
| CN101579330A (en) * | 2009-06-25 | 2009-11-18 | 中国农业大学 | Disinfectant for animals and preparation method thereof |
| CN109803532A (en) * | 2016-10-07 | 2019-05-24 | 荷兰联合利华有限公司 | Personal cleansing thimerosal |
| CN109997849A (en) * | 2019-04-28 | 2019-07-12 | 河北瑞鸿生物科技有限公司 | A kind of thimerosal and preparation method thereof |
-
2020
- 2020-03-20 CN CN202010198458.8A patent/CN111436429A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4320147A (en) * | 1980-05-09 | 1982-03-16 | Lonza Inc. | Disinfectant composition and the use thereof |
| CN101579330A (en) * | 2009-06-25 | 2009-11-18 | 中国农业大学 | Disinfectant for animals and preparation method thereof |
| CN109803532A (en) * | 2016-10-07 | 2019-05-24 | 荷兰联合利华有限公司 | Personal cleansing thimerosal |
| CN109997849A (en) * | 2019-04-28 | 2019-07-12 | 河北瑞鸿生物科技有限公司 | A kind of thimerosal and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 徐海涛等: "新一代杀菌剂双C8-10烷基二甲基氯化铵", 《辽宁化工》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112042645A (en) * | 2020-08-22 | 2020-12-08 | 西北工业大学 | A kind of compound quaternary ammonium salt disinfectant |
| CN112262846A (en) * | 2020-11-13 | 2021-01-26 | 中国科学院武汉病毒研究所 | Object surface disinfectant for high-grade biosafety laboratory and preparation method thereof |
| CN112655704A (en) * | 2020-12-23 | 2021-04-16 | 合肥天一生物技术研究所有限责任公司 | Quaternary ammonium salt composite disinfectant |
| WO2022135505A1 (en) * | 2020-12-23 | 2022-06-30 | 北京瞬行生物科技有限公司 | Composite quaternary ammonium salt disinfectant and preparation method therefor |
| CN112690277A (en) * | 2020-12-25 | 2021-04-23 | 广州艺境环保科技有限公司 | Sterilization material suitable for indoor space of hospital school and preparation method thereof |
| CN112970752A (en) * | 2021-03-01 | 2021-06-18 | 中国日用化学研究院有限公司 | Environment-friendly efficient surface disinfectant and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111436429A (en) | Pharmaceutical composition for environmental disinfection and preparation method thereof | |
| CA2940428C (en) | Stable compositions of uncomplexed iodine and methods of use | |
| CN102067870B (en) | Composition of disinfectant and preparation method thereof | |
| CN104055790B (en) | A kind of compound skin mucosa disinfectant and its preparation method and application | |
| CN107372681B (en) | Novel veterinary compound disinfectant and preparation method thereof | |
| CN112022732A (en) | Hand-washing-free disinfectant and preparation method thereof | |
| CN103445983B (en) | Novel biological sterilizing liquid soap | |
| US9308184B2 (en) | Powder composition for disinfection of the teats of dairy animals | |
| CN112120042A (en) | Hypochlorous acid disinfectant with efficient sterilization function and preparation method thereof | |
| CN111493097A (en) | Collective disinfectant for inhibiting viruses and pathogenic bacteria and preparation method thereof | |
| CN107094811A (en) | A kind of saliferous sterilization effervescent tablet used for aquiculture and preparation method thereof | |
| CN113694082A (en) | Hypochlorous acid disinfectant and preparation method thereof | |
| CN103329942B (en) | Compound disinfectant, and preparation method and applications thereof | |
| CN102948426B (en) | Novel food safety grade disinfection solution and preparation method thereof | |
| CN112106788A (en) | Low-odor low-corrosivity neutral disinfectant and preparation method thereof | |
| CN111493073A (en) | Surface disinfection film covering agent and preparation method thereof | |
| US12213991B2 (en) | Preparations for controlled-release of hypochlorous acid | |
| CN115152756B (en) | Inclusion compound disinfectant tablet and preparation method thereof | |
| CN101755763A (en) | Disinfection composition for preventing and treating livestock and poultry breeding diseases and prepration method and application thereof | |
| CN104904753A (en) | Efficient disinfectant and preparation method thereof | |
| CN104434994A (en) | Mucocutaneous disinfectant | |
| CN111328811B (en) | A kind of low-concentration alcohol sterilizing and disinfecting liquid and its application | |
| WO2022126976A1 (en) | Special disinfectant for meat, and preparation method therefor | |
| CN114631538A (en) | Disinfectant for panda colony house, preparation method and disinfection method | |
| CN106538592A (en) | A kind of mixture disinfectant for aquaculture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200724 |
|
| RJ01 | Rejection of invention patent application after publication |